Unraveling the immunogenic cell death pathways in gastric adenocarcinoma: A multi‐omics study

Author:

Gu Renjun12,Chen Zilu3,Dong Mengyue4,Li Ziyun5,Wang Min6,Liu Hao7,Shen Xinyu7,Huang Yan8,Feng Jin9,Mei Kun6ORCID

Affiliation:

1. School of Chinese Medicine Nanjing University of Chinese Medicine Nanjing China

2. Jinling Hospital, Affiliated Hospital of Medical School Nanjing University Nanjing China

3. Nanjing University of Chinese Medicine Nanjing China

4. Rehabilitation department Beijing Rehabilitation Hospital Affiliated to Capital Medical University Beijing China

5. School of Acupuncture and Tuina, School of Regimen and Rehabilitation Nanjing University of Chinese Medicine Nanjing China

6. Department of Cardiothoracic Surgery The Third Affiliated Hospital of Soochow University Changzhou China

7. Out‐patient department Eastern Theater General Hospital Nanjing China

8. Department of Ultrasound Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine Nanjing China

9. Department of Gastrointestinal Surgery The Third Affiliated Hospital of Soochow University Changzhou China

Abstract

AbstractBackgroundGastric cancer (GC) is a prevalent malignant tumor of the gastrointestinal (GI) system. However, the lack of reliable biomarkers has made its diagnosis, prognosis, and treatment challenging. Immunogenic cell death (ICD) is a type of programmed cell death that is strongly related to the immune system. However, its function in GC requires further investigation.MethodWe used multi‐omics and multi‐angle approaches to comprehensively explore the prognostic features of ICD in patients with stomach adenocarcinoma (STAD). At the single‐cell level, we screened genes associated with ICD at the transcriptome level, selected prognostic genes related to ICD using weighted gene co‐expression network analysis (WGCNA) and machine learning, and constructed a prognostic model. In addition, we constructed nomograms that incorporated pertinent clinical features and provided effective tools for prognostic prediction in clinical settings. We also investigated the sensitivity of the risk subgroups to both immunotherapy and drugs. Finally, in addition to quantitative real‐time polymerase chain reaction, immunofluorescence was used to validate the expression of ICD‐linked genes.ResultsBased on single‐cell and transcriptome WGCNA analyses, we identified 34 ICD‐related genes, of which 11 were related to prognosis. We established a prognostic model using the least absolute shrinkage and selection operator (LASSO) algorithm and identified dissimilarities in overall survival (OS) and progression‐free survival (PFS) in risk subgroups. The nomograms associated with the ICD‐related signature (ICDRS) demonstrated a good predictive value for clinical applications. Moreover, we detected changes in the tumor microenvironment (TME), including biological functions, mutation landscapes, and immune cell infiltration, between the high‐ and low‐risk groups.ConclusionWe constructed an ICD‐related prognostic model that incorporated features related to cell death. This model can serve as a useful tool for predicting the prognosis of GC, targeted prevention, and personalized medicine.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3